A multicentre phase II study of the efficacy and safety of docetaxel as first-line treatment of advanced breast cancer: Report of the Clinical Screening Group of the EORTC-Reference-Cited by-同舟云学术

A multicentre phase II study of the efficacy and safety of docetaxel as first-line treatment of advanced breast cancer: Report of the Clinical Screening Group of the EORTC

Published:1996-02 Issue:2 Volume:7 Page:165-171
ISSN:0923-7534
Container-title:Annals of Oncology
language:en
Short-container-title:Annals of Oncology

Author:

Fumoleau P.,Chevallier B.,Kerbrat P.,Krakowski Y.,Misset J.-L.,Maugard-Louboutin C.,Dieras V.,Azli N.,Bougon N.,Riva A.,Roche H.

Publisher

Elsevier BV

Subject

Oncology,Hematology

Link

http://academic.oup.com/annonc/article-pdf/7/2/165/359281/7-2-165.pdf

Reference27 articles.

1. Cancer in the European Community and its member states;Jensen;Eur J Cancer,1993

2. Cancer of the breast;Harris,1993

3. Metastatic breast cancer;Leonard;BMJ,1994

4. Systemic therapy of advanced breast cancer;Mouridsen;Drugs,1992

5. Taxol: A novel investigational antineoplastic agent;Rowinsky;J Natl Cancer Inst,1990

Cited by 73 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Aptamers for the Delivery of Plant-Based Compounds: A Review;Pharmaceutics;2024-04-14

2. Comparative study of dexamethasone premedication regimens with docetaxel chemotherapy in early HER-2 positive breast cancer: A safety net hospital experience;Journal of Oncology Pharmacy Practice;2024-02-29

3. An Overview of Cannabidiol as a Multifunctional Drug: Pharmacokinetics and Cellular Effects;Molecules;2024-01-18

4. Phase 1 Study to Evaluate the Safety of Reducing the Prophylactic Dose of Dexamethasone around Docetaxel Infusion in Patients with Prostate and Breast Cancer;Cancers;2023-03-09

5. Microtubule Inhibitors;Holland‐Frei Cancer Medicine;2023-02-20